GLP-1 & Metabolic Health
South Asians often develop insulin resistance at normal body weight — a pattern standard weight-based care models don't account for.
South Asians frequently carry higher visceral and ectopic fat at normal BMI, a pattern associated with insulin resistance and type 2 diabetes risk independent of body weight.
Source: Yajnik & Yudkin, “The Y-Y Paradox” (Lancet, 2004); International Diabetes Federation consensus on Asian metabolic risk
GLP-1 medication trials have been conducted predominantly in non-South Asian populations. Pairing treatment with metabolic biomarker tracking (HbA1c, fasting insulin, lipid panel) supports monitoring that reflects individual metabolic status rather than weight alone.
Source: American Diabetes Association Standards of Care (2024)
Early access
We're opening membership in limited cohorts. Join the waitlist for early access.
We never sell or share your data. One email when we launch — nothing else.
Preventive Health for South Asian Bodies